DBE tables for FDA submission [Regulatives / Guidelines]

posted by avinash – India, 2014-01-27 12:59 (4534 d 20:08 ago) – Posting: # 12274
Views: 8,051

Dear Members,

My question with regard to DBE tables for FDA submission studies.

Under Table 9 “Reanalysis of Study Samples”

Two sections are there
1) Number of samples reanalyzed
2) Number of recalculated values used after reanalysis

Can any one please explain me what is the difference between these two sections?

Thanks & regards,
Avinash Jain

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
400 visitors (0 registered, 400 guests [including 24 identified bots]).
Forum time: 10:07 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5